A new understanding of the epigenetic and genetic causes of paediatric brain tumours has recently emerged revealing potential novel targets for drug development, including the growth factor receptor ALK2, encoded by the gene ACVR1. The gene discussed is ACVR1; the disease is brain neoplasm.